Loading insider details...
Latest Form 4 (Jul 13, 2026): Exercise/Conversion of 17,167 BBIO shares, $287.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 17,167 | $287.5K |
| Jun 24, 2026 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 3,990 | n/a |
| Mar 6, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 64,921 | $548.6K |
| Aug 7, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 17,167 | $287.5K |
| Jun 24, 2025 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 6,589 | n/a |
| Apr 16, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 10,000 | $84.5K |
| Apr 3, 2025 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 30,000 | $253.5K |
| Jun 25, 2024 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 26,014 | n/a |
| Jun 23, 2023 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 51,501 | n/a |
| Jun 24, 2022 | BridgeBio Pharma, Inc. (BBIO) | Grant/Award | 104,921 | n/a |